Australia, Nov. 11 -- Crinetics Pharmaceuticals Inc., owns the trademark (2580300) for 'PALFYDEV' till Aug. 25, 2035.
Status: registered:
Registered/protected
Classes: 5 [Pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating endocrine disorders and endocrine-related diseases; pharmaceutical preparations for the treatment of acromegaly, carcinoid syndrome, neuroendocrine tumors, and cancer; all for human use.] and 5 [Pharmaceutical preparations for use in oncology;pharmaceutical preparations for use in treating endocrine disorders and endocrine-related diseases;pharmaceutical preparations for the treatment of acromegaly, carcinoid syndrome, neuroendocrine tumors, and cancer;all for human use]
Type of Mark: Word
Date of Acceptance: Sept. 3
Registration Advertised: Nov. 10
For further details contact Spruson & Ferguson.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2580300.
Disclaimer: Curated by HT Syndication.
